Interleukin 21 Receptor Affects Adipogenesis of Human Adipose-Derived Stem/Stromal Cells

Bruna Cristina Falavinha1, María Julia Barisón1, Carmen Lúcia Kuniyoshi Rebelatto2

  • 1Laboratory for Basic Biology of Stem Cells (LABCET), Instituto Carlos Chagas-FIOCRUZ-PR, Curitiba, Paraná 81830-010, Brazil.

Stem Cells International
|January 20, 2022
PubMed

Insights

Interleukin 21 receptor (IL21R) plays a crucial role in adipocyte formation. Silencing IL21R in adipose-derived stem cells reduced their ability to differentiate into fat cells, impacting obesity-related diseases.

Area of Science:

  • Cell Biology
  • Metabolic Diseases
  • Stem Cell Research

Background:

  • Adipose tissue dysfunction is linked to metabolic diseases.
  • Adipocyte differentiation is key to understanding these conditions.
  • Interleukin 21 receptor (IL21R) is implicated in metabolic diseases but its role in stem cells is understudied.

Purpose of the Study:

  • To investigate the function of IL21R in human adipose-derived stem/stromal cells (ADSCs).
  • To determine the effect of IL21R on ADSC adipogenic differentiation.

Main Methods:

  • Confocal immunofluorescence assays to assess IL21R localization.
  • IL21R gene silencing and overexpression in ADSCs.
  • Assessment of cell proliferation, mitochondrial activity, and adipogenic capacity.

Main Results:

  • IL21R was found to colocalize with mitochondrial proteins (ATP5B, ALDH4A1) and the nucleus in human ADSCs.
  • IL21R modulation did not impact ADSC proliferation or mitochondrial activity.
  • Silencing IL21R significantly reduced the adipogenic capacity of ADSCs.

Conclusions:

  • IL21R is important for adipogenic differentiation of ADSCs.
  • The precise mechanism linking IL21R to adipogenesis requires further investigation.

Related Concept Videos